U.S. FDA Approves Eisai's Dayvigo (Lemborexant) for Treatment of Insomnia in Adult Patients - Benzinga

Submitted by Anonymous (not verified) on Mon, 12/23/2019 - 01:20

U.S. FDA Approves Eisai's Dayvigo (Lemborexant) for Treatment of Insomnia in Adult Patients  Benzinga